Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Mar 25, 2016 12:03pm
369 Views
Post# 24700689

vanc has worldwide rights to FerroHemme and Pedia-Safe...

vanc has worldwide rights to FerroHemme and Pedia-Safe...Unlike RX , Vanc has worldwide rights to its OTC products ...I have always felt this is why they chose  the current shell as their public vehicle, since it had the valuable OTC products ..As I recall Vanc actually developed the OTC products over several years... and I think they only need simple appliactions filed to enter other countries, not any trials....
I have also been thinking for some time that the OTC products is where we could see some significant news coming from Vanc, from reading the tea leaves...
Any unique products (whether generic ot OTC, or brand drug)  are great because they can be used as a door openener for Vanc in landing a new pharmacy account.....FerroHemme sounds like it could act in this way, and so indirectly help sell the whole Vanc platform...
Bullboard Posts